The anti-angiogenic 8-epipuupehedione behaves as a potential anti-leukaemic compound against HL-60 cells

J Cell Mol Med. 2008 Apr;12(2):701-6. doi: 10.1111/j.1582-4934.2007.00134.x.

Abstract

We have previously reported that 8-epipuupehedione, a synthetic derivative of sesquiterpenes found in several kinds of sponges, is a potent inhibitor of angiogenesis. Here, we show that 8-epipuupehedione is also a potent anti- leukaemic compound, targeting three hallmarks of malignancy: proliferation, survival and extra-cellular matrix re-modelling. To fulfil this goal, we use the HL-60 promyeolocytic cells as our model system and the following experimental procedures: cell growth assay, Hoetsch staining, cell cycle analysis and DNA fragmentation, caspase 3 activity and zymographic assays. Our results show that this compound inhibits proliferation and has potent and specific pro-apoptotic effects on HL-60 promyelocytic cells, inducing their nuclei and DNA fragmentation, as well as caspase 3 activity activation. Furthermore, 8-epipuupehedione strongly inhibits matrix metalloproteinase-2 and urokinase production by HL-60 cells. These results suggest that 8-epipuupehedione could be an attractive drug for further evaluation in the treatment of leukemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Aorta / cytology
  • Apoptosis / drug effects
  • Caspase 3 / metabolism
  • Cattle
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • DNA Fragmentation / drug effects
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects
  • Endothelium, Vascular / cytology
  • Enzyme Activation / drug effects
  • Extracellular Matrix / drug effects
  • HL-60 Cells
  • Humans
  • Inhibitory Concentration 50
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase Inhibitors
  • Terpenes / pharmacology*
  • Time Factors
  • Urokinase-Type Plasminogen Activator / antagonists & inhibitors

Substances

  • 8-epipuupehedione
  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Matrix Metalloproteinase Inhibitors
  • Terpenes
  • Urokinase-Type Plasminogen Activator
  • Caspase 3
  • MMP2 protein, human
  • Matrix Metalloproteinase 2